SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000827809-18-000025
Filing Date
2018-07-11
Accepted
2018-07-11 16:01:48
Documents
7
Period of Report
2018-08-09
Effectiveness Date
2018-07-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A nvln-12312017xdef14a.htm DEF 14A 1417833
2 companylogo.jpg GRAPHIC 8423
3 novelionsedarproxye01page1.jpg GRAPHIC 399576
4 novelionsedarproxye01page2.jpg GRAPHIC 296771
5 signature.jpg GRAPHIC 7992
6 signaturea02.jpg GRAPHIC 7992
7 signaturea03.jpg GRAPHIC 7992
  Complete submission text file 0000827809-18-000025.txt   2412109
Mailing Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3
Business Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3 (877) 764-3131
NOVELION THERAPEUTICS INC. (Filer) CIK: 0000827809 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-17082 | Film No.: 18948760
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1